Activated Charcoal Oral Suspension shortage
To Be Discontinued 5 presentations · 1 manufacturers · first FDA posting May 15, 2026 · last update May 15, 2026
Manufacturers: Padagis US LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-74) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted May 15, 2026 Updated May 15, 2026 Discontinued May 15, 2026 |
| Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-76) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted May 15, 2026 Updated May 15, 2026 Discontinued May 15, 2026 |
| Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-25) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted May 15, 2026 Updated May 15, 2026 Discontinued May 15, 2026 |
| Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-74) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted May 15, 2026 Updated May 15, 2026 Discontinued May 15, 2026 |
| Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-76) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted May 15, 2026 Updated May 15, 2026 Discontinued May 15, 2026 |